246 related articles for article (PubMed ID: 29417044)
1. Antibody targeting of phosphatidylserine for the detection and immunotherapy of cancer.
Belzile O; Huang X; Gong J; Carlson J; Schroit AJ; Brekken RA; Freimark BD
Immunotargets Ther; 2018; 7():1-14. PubMed ID: 29417044
[TBL] [Abstract][Full Text] [Related]
2. Blocking antibody-mediated phosphatidylserine enhances cancer immunotherapy.
Zhang J; Dai Z; Yan C; Wang D; Tang D
J Cancer Res Clin Oncol; 2021 Dec; 147(12):3639-3651. PubMed ID: 34499223
[TBL] [Abstract][Full Text] [Related]
3. Targeting phosphatidylserine for Cancer therapy: prospects and challenges.
Chang W; Fa H; Xiao D; Wang J
Theranostics; 2020; 10(20):9214-9229. PubMed ID: 32802188
[TBL] [Abstract][Full Text] [Related]
4. TIMs, TAMs, and PS- antibody targeting: implications for cancer immunotherapy.
Dayoub AS; Brekken RA
Cell Commun Signal; 2020 Feb; 18(1):29. PubMed ID: 32087708
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylserine: The Unique Dual-Role Biomarker for Cancer Imaging and Therapy.
Kaynak A; Davis HW; Kogan AB; Lee JH; Narmoneva DA; Qi X
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626139
[TBL] [Abstract][Full Text] [Related]
6. Tumor-specific targeting by Bavituximab, a phosphatidylserine-targeting monoclonal antibody with vascular targeting and immune modulating properties, in lung cancer xenografts.
Gerber DE; Hao G; Watkins L; Stafford JH; Anderson J; Holbein B; Öz OK; Mathews D; Thorpe PE; Hassan G; Kumar A; Brekken RA; Sun X
Am J Nucl Med Mol Imaging; 2015; 5(5):493-503. PubMed ID: 26550540
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers.
Gray MJ; Gong J; Hatch MM; Nguyen V; Hughes CC; Hutchins JT; Freimark BD
Breast Cancer Res; 2016 May; 18(1):50. PubMed ID: 27169467
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer.
Birge RB; Boeltz S; Kumar S; Carlson J; Wanderley J; Calianese D; Barcinski M; Brekken RA; Huang X; Hutchins JT; Freimark B; Empig C; Mercer J; Schroit AJ; Schett G; Herrmann M
Cell Death Differ; 2016 Jun; 23(6):962-78. PubMed ID: 26915293
[TBL] [Abstract][Full Text] [Related]
9. A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer.
Chalasani P; Marron M; Roe D; Clarke K; Iannone M; Livingston RB; Shan JS; Stopeck AT
Cancer Med; 2015 Jul; 4(7):1051-9. PubMed ID: 25826750
[TBL] [Abstract][Full Text] [Related]
10. Targeting Phosphatidylserine Enhances the Anti-tumor Response to Tumor-Directed Radiation Therapy in a Preclinical Model of Melanoma.
Budhu S; Giese R; Gupta A; Fitzgerald K; Zappasodi R; Schad S; Hirschhorn D; Campesato LF; De Henau O; Gigoux M; Liu C; Mazo G; Deng L; Barker CA; Wolchok JD; Merghoub T
Cell Rep; 2021 Jan; 34(2):108620. PubMed ID: 33440157
[TBL] [Abstract][Full Text] [Related]
11. Biological Function and Immunotherapy Utilizing Phosphatidylserine-based Nanoparticles.
Glassman FY; Dingman R; Yau HC; Balu-Iyer SV
Immunol Invest; 2020 Oct; 49(7):858-874. PubMed ID: 32204629
[TBL] [Abstract][Full Text] [Related]
12. Profile of bavituximab and its potential in the treatment of non-small-cell lung cancer.
Stasi I; Cappuzzo F
Lung Cancer (Auckl); 2014; 5():43-50. PubMed ID: 28210141
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylserine-mediated oral tolerance.
Nguyen NH; Chak V; Keller K; Wu H; Balu-Iyer SV
Cell Immunol; 2023 Feb; 384():104660. PubMed ID: 36586393
[TBL] [Abstract][Full Text] [Related]
14. Detection of apoptosis in ovarian cells in vitro and in vivo using the annexin v-affinity assay.
Engeland M; van den Eijnde SM; Aken T; Vermeij-Keers C; Ramaekers FC; Schutte B; Reutelingsperger CP
Methods Mol Med; 2001; 39():669-77. PubMed ID: 21340828
[TBL] [Abstract][Full Text] [Related]
15. Antibody-Mediated Blockade of Phosphatidylserine Enhances the Antitumor Effect of Sorafenib in Hepatocellular Carcinomas Xenografts.
Cheng X; Li L; Thorpe PE; Yopp AC; Brekken RA; Huang X
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):583-591. PubMed ID: 26847681
[TBL] [Abstract][Full Text] [Related]
16. Phosphatidylserine externalization as immune checkpoint in cancer.
Kur IM; Weigert A
Pflugers Arch; 2024 Apr; ():. PubMed ID: 38573347
[TBL] [Abstract][Full Text] [Related]
17. How are necrotic cells recognized by their predators?
Li Z; Zhou Z
Worm; 2016; 5(1):e1120400. PubMed ID: 27073733
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylserine-Targeted Nanotheranostics for Brain Tumor Imaging and Therapeutic Potential.
Wang L; Habib AA; Mintz A; Li KC; Zhao D
Mol Imaging; 2017 Jan; 16():1536012117708722. PubMed ID: 28654387
[TBL] [Abstract][Full Text] [Related]
19. Phosphatidylserine: A cancer cell targeting biomarker.
Sharma B; Kanwar SS
Semin Cancer Biol; 2018 Oct; 52(Pt 1):17-25. PubMed ID: 28870843
[TBL] [Abstract][Full Text] [Related]
20. Measuring response to therapy by near-infrared imaging of tumors using a phosphatidylserine-targeting antibody fragment.
Gong J; Archer R; Brown M; Fisher S; Chang C; Peacock M; Hughes C; Freimark B
Mol Imaging; 2013 Jun; 12(4):244-56. PubMed ID: 23651502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
